Details of the Drug

General Information of Drug (ID: DMUTHWF)

Drug Name

ExpressGraft

Indication

Disease Entry	ICD 11	Status	REF
Diabetic foot ulcer	BD54	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04134143) An Open-Label, Prospective, Safety, and Tolerability Study of ExpressGraft- C9T1 Skin Tissue in the Treatment of Diabetic Foot Ulcers. U.S.National Institutes of Health.